Indaptus Therapeutics Inc (INDP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $422.38M
Last updated: Nov 17, 2026 at 11:04 AM ET
Indaptus Therapeutics Inc (INDP) Stock Forecast
Analysts expect Indaptus Therapeutics (INDP) to earn -$6.43 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$4.48.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$6.43
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$4.48
- EPS consensus
- Next report
- Mar 15, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$6.43 | -$6.43 to -$6.43 | 1 |
| Dec 31, 2027 | -$4.48 | -$4.48 to -$4.48 | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$13.90.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$6.43 | -$13.90 | -$13.90 | -$13.90 | -$13.90 | N/A |
| Fiscal year ending Dec 31, 2027 | -$4.48 | -$12.75 | -$12.75 | -$12.75 | -$12.75 | N/A |
Frequently Asked Questions About INDP
What is the INDP stock forecast?
Consensus analyst estimates put Indaptus Therapeutics's EPS at -$6.43 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from INDP next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$6.43, with estimates from -$6.43 to -$6.43 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$4.48, with estimates from -$4.48 to -$4.48 from 1 analyst.
How many analysts cover INDP?
1 analyst estimates EPS for Indaptus Therapeutics for the fiscal year ending Dec 31, 2026.
INDP pages: Overview, Earnings, Forecast, Financials, Competitors